Luca Quartuccio

Overview

Best Publications

• A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.

  S De Vita;L Quartuccio;M Isola;C Mazzaro

  483
  Citations

• Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study

  Xavier Mariette;Raphaèle Seror;Luca Quartuccio;Gabriel Baron

  361
  Citations

• Primary Sjögren’s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients

  Chiara Baldini;Pasquale Pepe;Luca Quartuccio;Roberta Priori

  299
  Citations

• Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients.

  Maurizio Pietrogrande;Salvatore De Vita;Anna Linda Zignego;Pietro Pioltelli

  255
  Citations

• Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium.

  Pilar Brito-Zerón;Pilar Brito-Zerón;Nihan Acar-Denizli;Margit Zeher;Astrid Rasmussen

  223
  Citations

• Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course

  Lorenzo Cavagna;Ernesto Trallero-Araguás;Federica Meloni;Ilaria Cavazzana

  217
  Citations

• Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids

  L. Quartuccio;G. Soardo;G. Romano;F. Zaja

  210
  Citations

• Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.

  Lorenzo Cavagna;Laura Nuño;Carlo Alberto Scirè;Marcello Govoni

  200
  Citations

• Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population‐based multicentre cohort study

  E. Bartoloni;C. Baldini;G. Schillaci;L. Quartuccio

  197
  Citations

• BLyS upregulation in Sjögren’s syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands

  Luca Quartuccio;Sara Salvin;Martina Fabris;Marta Maset

  179
  Citations

• Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.

  Luca Quartuccio;Miriam Isola;Chiara Baldini;Roberta Priori

  178
  Citations

• International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management

  Roberto Giacomelli;Antonella Afeltra;Alessia Alunno;Chiara Baldini

  169
  Citations

• COVID 19: a clue from innate immunity.

  Domenico Birra;Maurizio Benucci;Luigi Landolfi;Anna Merchionda

  167
  Citations

• Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care.

  Luca Quartuccio;Arianna Sonaglia;Dennis McGonagle;Martina Fabris

  159
  Citations

• Efficacy and safety of belimumab given for 12 months in primary Sjögren’s syndrome: the BELISS open-label phase II study

  Salvatore De Vita;Luca Quartuccio;Raphaèle Seror;Sara Salvin

  158
  Citations

• Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study

  Alessandra Bettiol;Maria Letizia Urban;Lorenzo Dagna;Vincent Cottin

  153
  Citations

• Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations

  Pilar Brito-Zerón;Elke Theander;Chiara Baldini;Raphaèle Seror

  151
  Citations

• B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection

  M. Fabris;L. Quartuccio;S. Sacco;G. De Marchi

  147
  Citations

• Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis

  Luca Quartuccio;Martina Fabris;Sara Salvin;Fabiola Atzeni

  138
  Citations

• How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project).

  Pilar Brito-Zerón;Nihan Acar-Denizli;Wan-Fai Ng;Margit Zeher

  135
  Citations

• Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives.

  Maria Infantino;Arianna Damiani;Francesca Li Gobbi;Valentina Grossi

  134
  Citations

• AB0156 Thymic stromal lymphopoietin (TSLP) in primary sjÖgren's syndrome and related lymphoma: the possible contribution of a novel growth factor

  S Gandolfo;C Fabro;M Bulfoni;S Russi

  133
  Citations